169 related articles for article (PubMed ID: 29440172)
1. A Distinct Oncogenerative Multinucleated Cancer Cell Serves as a Source of Stemness and Tumor Heterogeneity.
Díaz-Carballo D; Saka S; Klein J; Rennkamp T; Acikelli AH; Malak S; Jastrow H; Wennemuth G; Tempfer C; Schmitz I; Tannapfel A; Strumberg D
Cancer Res; 2018 May; 78(9):2318-2331. PubMed ID: 29440172
[TBL] [Abstract][Full Text] [Related]
2. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
[TBL] [Abstract][Full Text] [Related]
4. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
6. Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells.
Qian H; Ding X; Zhang J; Mao F; Sun Z; Jia H; Yin L; Wang M; Zhang X; Zhang B; Yan Y; Zhu W; Xu W
Oncotarget; 2017 Jun; 8(24):39522-39533. PubMed ID: 28465472
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
8. Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis.
Romano S; Tufano M; D'Arrigo P; Vigorito V; Russo S; Romano MF
Semin Cancer Biol; 2020 Feb; 60():181-190. PubMed ID: 31422157
[TBL] [Abstract][Full Text] [Related]
9. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.
Chang CJ; Chien Y; Lu KH; Chang SC; Chou YC; Huang CS; Chang CH; Chen KH; Chang YL; Tseng LM; Song WS; Wang JJ; Lin JK; Huang PI; Lan YT
Biochem Biophys Res Commun; 2011 Nov; 415(2):245-51. PubMed ID: 22037460
[TBL] [Abstract][Full Text] [Related]
10. Human endogenous retroviruses role in cancer cell stemness.
Matteucci C; Balestrieri E; Argaw-Denboba A; Sinibaldi-Vallebona P
Semin Cancer Biol; 2018 Dec; 53():17-30. PubMed ID: 30317035
[TBL] [Abstract][Full Text] [Related]
11. The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB.
Garcia-Heredia JM; Lucena-Cacace A; Verdugo-Sivianes EM; Pérez M; Carnero A
Clin Cancer Res; 2017 Jul; 23(14):3871-3883. PubMed ID: 28153862
[No Abstract] [Full Text] [Related]
12. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.
Cortini M; Massa A; Avnet S; Bonuccelli G; Baldini N
PLoS One; 2016; 11(11):e0166500. PubMed ID: 27851822
[TBL] [Abstract][Full Text] [Related]
14. Intra-tumor heterogeneity from a cancer stem cell perspective.
Prasetyanti PR; Medema JP
Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
16. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.
Natarajan TG; Ganesan N; Fitzgerald KT
Cancer Biomark; 2010; 9(1-6):65-99. PubMed ID: 22112470
[TBL] [Abstract][Full Text] [Related]
18. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
19. Cancer stemness, intratumoral heterogeneity, and immune response across cancers.
Miranda A; Hamilton PT; Zhang AW; Pattnaik S; Becht E; Mezheyeuski A; Bruun J; Micke P; de Reynies A; Nelson BH
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9020-9029. PubMed ID: 30996127
[TBL] [Abstract][Full Text] [Related]
20. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
